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SUMMARY 
In sub-Saharan Africa, it is estimated that 80% of the population depends on indigenous medicines for 
primary health-care. These herbs often contain highly active pharmacological compounds whose 
pharmacotherapeutic and toxicity profiles have not been well characterized. Toxicity may be related to several 
intrinsic and extrinsic factors. Most of the available reports related to the toxic effects of herbal medicines 
cite hepatoxicity as the most frequently experienced toxicity. However, noxious effects involving kidneys, the 
nervous system, skin, blood, the cardiovascular system, mutagenicity and carcinogenicity have also been 
published. This article presents a systematic review on safety and toxicity of herbal medicines used in Kenya. 
Keywords: Herbal medicine, herbal preparations, toxicity, Kenya, regulations, complementary and alternative 
medicine.  
[Afr J Health Sci. 2013; 24:2947] 
Introduction  
Herbal medicine is an important part of the culture and 
traditions of most African communities. Kenya in 
particular has a rich and diverse repertoire of flora that 
has been used by various ethnic communities as 
medicines for centuries. Ethnobotanical information 
and usage of traditional herbal medicine by different 
ethnic communities in Kenya has been investigated by 
several researchers   (Jeruto et al., 2006; Bussman, 
2006; Nguta et al., 2010; Njoroge et al., 2010; Kareru 
et al., 2008; Nagata et al., 2011; Nanyingi et al., 
2008). According to some estimates, traditional 
healers provide the first line of care for 8090% of the 
population (Lambert et al., 2011). While herbal usage, 
especially in rural communities is high, an estimated 
23% of the sick do not seek conventional health care 
(Njoroge et al., 2010; Muthaura et al., 2011). The 
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importance of herbal medicines in Kenya is further 
evidenced by the fact that traditional herbal medical 
practitioners (THMPs) far outnumber conventional or 
allopathic providers. Given the estimated 40,000 
THMPs and assuming a population of 38 million 
Kenyans, there is a THMP  patient ratio of 1 to 950 
(Lambert et al., 2011). Currently, the conventional 
doctor to patient ratio stands at 1 to 33 000 (Ibid).  
The growing popularity of herbal medicines has been 
attributed to a number of factors including accessibility, 
affordability, aggressive marketing by THMP and the 
perception that herbal medicines are natural hence 
safe (Sahoo et al., 2010). Parallel with the growing 
popularity is an increasing interest in the scientific 
rationale for plant usage. Towards this end, several 
research groups in Kenya have investigated the 
efficacy of specific herbs. Crude or fractionated 
extracts of medicinal herbs have been screened in 
invitro and in vivo systems for antibacterial (Kareru et 
al., 2008; Matasyoh et al., 2008); antiviral (Kanyara et 
al., 2005) and antiplasmodial activity (Kigondu et al., 
2011; Wagate et al., 2008). Still, little is known about 
their mechanisms of actions. Another aspect, which is 
largely under investigated is the toxicity associated 
with the use of herbs (Huxtable, 1990).  This should 
raise some concern given the recent warnings by 
biomedical health practitioners on the potential adverse 
effects of herbal remedies.  In this paper, we evaluate 
the safety and toxicity herbal medicines used in the 
country.  
 
Herbal Medicine in Kenya  
Current regulatory status  
Herbal medicine practitioners in Kenya are registered 
by the Ministry of Culture and Social Services. 
Registration is nonobligatory and is subject to the 
requirement that herbal medicines used should be 
should be submitted to national laboratories, namely: 
Kenya Medical Research Institute (KEMRI), Nairobi 
University’s Mitishamba Drug Research Unit (MDRU) 
and Government Chemists (GC) for evaluation of 
safety. However, toxicity tests on the herbal 
preparations presented are mostly not done. These 
institutions mainly rely on literature search to predict 
the efficacy and safety of the herbs. The literature 
review has some important shortcomings, for instance: 
most of these studies are directed at the toxicological 
properties of single plant formulations. However, the 
labels on most herbal preparations, especially those 
sold as panaceas for common chronic diseases; 
indicate that most contain multiple herbs.  
For mass produced herbal products, registration is 
done by the Pharmacy and Poisons Board of Kenya 
(PPBK) under the Ministry of Health Services. 
However, PPBK relies, in part, on the same 
laboratories mentioned earlier and is thus subject to 
the same challenges highlighted above.  In addition, 
the regulatory scheme by PPBK covers only Good 
Manufacturing Practices (GMP) and Good Supply 
Practices (GSP) but not Good Agricultural and 
Collection Practices (GACP). Figure 1 shows the 
circulation of herbal medicines in Kenya and how these 
regulatory regimes apply. 
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Figure 1: Flow diagram of the circulation of herbal medicines in Kenya.   
 
Red flow lines represent non regulated channels of the 
flow of herbal medicines or materials; The blue flow 
lines represent part of the channel regulated by the 
Ministy of Culture. However, most herbal medicine 
practitioners are not registered by the Ministry of 
Culture. Therefore the blue line represents partial 
regulation.  The black flow lines represent part of the 
channel regulated by the Poisons and Pharmacy Board 
(PPB).     
Safety concerns and challenges in the regulation of 
herbal preparations are many and include:  
• Some practitioners combine herbal treatment 
with spirituality making regulation difficult (Kokwaro, 
1993).  
• There are unscrupulous traders/healers who 
typically use misleading adverts to market their 
products. This has prompted to the establishment of 
guidelines for advertisement and promotion of herbal 
products (Robison, 2011). However, the enforcement 
of these guidelines remains a challenge. 
• There is a general decline in authentic 
knowledge of traditional remedies; this issue has 
health implications since sourcing of herbs by non
experts can results in misidentification which may lead 
to the inadvertent use of toxic herbs.  
• There are no forums for exchange of 
information/knowledge among the herbal medical 
practitioners (THMPs), and conventional medical 
practitioners (Lambert et al., 2011).  
• Further, the emerging nontraditional use of 
herbal preparation (e.g., use of sliming products and 
herbal teas) may lead to prolonged use. Such 
prolonged usages enhance the likelihood of cumulative 
toxic consequences (Aronson, 2009).  
• Pharmacovigilance for herbal medicines is 
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Risks associated with herbal medicines. 
This may be attributed to a number of quality related 
issues (Zhang et al., 2011). From cultivation of 
medicinal herbs to the final product, several factors 
(internal and external) can influence quality.  
External Quality Issues  
External quality issues include: contamination, 
adulteration, substitution and misidentification. 
Contamination and substitution of herbal 
medicines  
Contamination of herbal medicines with heavy metals 
(Lead (Ld), Cadmium (Cd), Mercury (Hg), Arsenic 
(Ag), misidentified plants, pesticides, excessive levels 
of microorganisms or their toxins and other noxious 
organic materials are possible sources of danger in 
nonregulated use of herbal medicines (Mobusz et al., 
2006; Aronson, 2009). Contamination can occur at 
any stage from harvesting through packaging and 
storage (WHO, 2005). Experts believe that toxicities 
associated with herbal medicines are mostly due to 
these contaminants and clinical reports have vindicated 
this belief (Robinson et al., 2011). A recent study in 
Kenya, found that 67% of the herbal samples had 
bacterial count in the range of 6.00 × 105 to 1.56 × 
1010 cfu/ ml and fungal count in the range of 5.30 × 
104 to 1.56 × 109 cfu/ ml. Analysis confirmed the 
presence of microbes including, Escherichia coli, 
Shigella spp, Klebsiella pneumonia (Onyambu, 2011).  
Adulteration of herbal medicines  
Another area of concern is the adulteration of herbal 
medicines with conventional drugs or other plant 
materials (WHO, 2005). For instance, a study 
spanning 1990 to 2001 which evaluated 41 products 
out of 3320 Chinese Proprietary Medicines (CPM) sold 
in Singapore reported that all these products were 
contaminated with nineteen synthetic drugs (Sahoo et 
al., 2010). When 243 proprietary herbal formulations 
in California were tested, it was revealed that 7% 
contained undeclared pharmaceuticals (nonsteroidal 
antiinflammatory drugs (NSAIDs) and antihistamines, 
among others) (Phua and Heard, 2009). Since some 
herbs sold in the Country are imported from China, it 
can be asserted that Kenyans are exposed to the 
dangers posed by the presence of undeclared 
pharmaceuticals in TCM. In fact, reports published 
recently by the PPB indicate that some Chinese herbal 
contraceptives sold in the country contain high levels 
of conventional contraceptive (levonorgestrel and 
quinestrol) (PPB, 2012). Children born to mothers 
using these concoctions presented with several 
complications including preconscious sexual maturity, 
edema, muscular pain and impaired speech (PPB, 
2012; Nzioki, 2011; Okwemba 2010).  
Internal quality issues  
Internal quality challenges are related to the 
pharmacologically active phytochemicals present in a 
formulation (Zhang et al., 2011).  
Dosage of the active compounds  
The concentration of bioactive phytochemicals is 
determined by several factors including geographical 
(Matasyoh et al., 2008) and environmental factors 
(Zhang et al., 2011), species differences, part of the 
plant used, diurnal and seasonal variations (Saad et 
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al., 2001; Snodgrass, 2001; Farhat et al., 2001), soil 
composition and its contaminants and length of storage 
(Stickel et al., 2005). This means that without proper 
standardization, the actual dose of bioactive 
compounds being consumed is often variable, 
unpredictable or simply unknown. Indeed, batchto
batch variation of pharmacologically active constituents 
of herbal formulations presents a major problem when 
it comes to standardization of herbal medicines 
(Mobusz et al., 2006). While testing the antimicrobial 
activity of hydro  distilled volatile oils from the leaves 
of Ocimum gratissimum L. (Lamiaceae) of 13 
populations of different silvicultural zones in Kenya; a 
recent analytical study found significant variation in the 
antibacterial activity of the essential oils sourced from 
different parts of the country (Matasyoh et al., 2008). 
Plants sourced from the Meru region had the greatest 
strength. Such variation in dosage may have greater 
effects in special group including children, geriatrics, 
invalids, and malnourished/undernourished, drug users, 
HIV/AIDS patients, patients with liver or kidney 
complications and those on long term medications 
(Snodgrass, 2001). 
Toxicity of some commonly used herbs in Kenya 
Literature on toxicity of herbal medicines used by 
THMPs in Kenya is generally scant. Therefore, many 
questions regarding the safety and toxicity of specific 
herbs used in Kenya cannot be answered definitely by 
the available scientific data. However, the fact that 
some of the herbs used by THMPs are toxic cannot be 
discounted. This is underscored by the fact that some 
plants used in the country like Aristocholia sp. are 
listed by the European Commission’s Committee for 
Proprietary Medicinal Products (CPMP) as plants 
which pose serious health risks (Kokwaro, 1993; 
Hamill et al., 2000). In Table 1 below, we present a 
list of the toxicological profiles of some commonly used 
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Table1: Toxicity of some commonly used herbs  
Family  Species  Common 




Ethnic Group  Indications 
and  Parts 
used   














ache.  Tooth 
ache, cough   
Antiandrogenic and 
abortificant property. 
elevation of thyroid 
hormone levels† 
Unknown  Anuja et al., 2010 
 Tahiliani and   Kar., 2000 


















Oleander   
 













 Donald., 2008 








 Cardiovascular effects† Cardiac 
glycosides 





 LV Turkana (10)   chest pain  Nephropathy  and  
Carcinogenicity   
Aristolochic 
acid  
 Worbs et al., 2011 
Aristolochia 
petersiana  




 Worbs et al., 2011 
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Aspidiaceae Pteridium 
aquilinum 





Latorre et al., 2011 
Balanitaceae Balanites 
aegyptiaca 
Balanites  LV, BK, 
FR 
Luo (8); Nandi 
(1)  





Cardiovascular effect † Unknown   Mohamed et al.,1999 




BK,FR Luo (8); Kikuyu 
(10);  Meru  (7); 
Taita and  
Luyha (10)  
 Stomach 
ache, anemia, 
cold, flu  
Potentially mutagenicity  Unknown  Fennell et al., 2004 
Brassicaceae  Heliotropium 
subulatum  





carcinogenic   
Pyrrolizidine 
alkaloids  
 Donald., 2008 




BK Luhya, Kikuyu, 
Maasai, 
 Muscle pain, 
fever, cough  





LV, BK Kamba and  
Luo (10) 
 Asthma and 
abdominal 
Human fatalities 
reported following root 
Stachydrine Duke et al ., 2002 
Maerua edulis   RT Taita (10)  Syphilis and  
gonorrhea  






RT Nandi (1).  Stomach 
ache, diarrhea 
Liver and muscle 
degeneration especially 
in animals  
Unknown  Yadav et al., 2010  Barbosa  
et al. ,2005 
Ferreiro et al., 2009 
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Cassia 
occidentalis) 








Cardiovascular effects Cathinone  Getahun et al., 2010 
 Duke et al ., 2002 
Aronson et al., 2009 
 Tithonia  
diversifolia 







acute toxicity of liver 
and kidney † 
Unknown  Elifioye et al., 2009 
 Duke et al ., 2002 
Bidens pilosa Spanish 
Needles  
LV Luo (1), Meru 
and . Mbeere 
 Stomach 
ache, 



























weight loss.  
Kerato  conjunctivitis ,  








a Cactus  




Kerato  conjunctivitis,  
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Croton 
macrostachyus  
 LV Luyha, Meru, 




Malaria and  
Venereal 
Phorbol esters  Diterpene 
hydrocarbons 










nausea, vertigo and 
Curcin  Donald., 2008 
Ricinus 
communis  








Ribosome  inactivation, 
hypersensitivity 
reactions , Genotoxic†   
Ricin (mostly 
in seeds) 
 Aronson et al., 2009 




Jequirity  LV, BK, 
RT 






Ribosome inhibitor† Abrin (mostly 
in seeds) 





Neem  LV Luo (8); 
Akamba (5); 
Meru, Mbeere 











Boeke et al., 2004      
Melia 
azedarach 
Chinaberry LV Luo (8); Kikuyu 
(10) 








Ferreiro et al., 2009 
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Fennell et al., 2004 Duke 

























gingivitis    
 
Hypersensitivity 
reaction. Should not be 
used for a period 
















Maasai (3); Miji 





Potentially carcinogenic  
 
 
Estragole  Duke et al ., 2002  





Meru, Luo (10) 
purgative  GIT irritation  Sennosides   Donald., 2008 
Liliaceae 
 
Aloe vera  Aloe  LV Used nationally    Swelling, 
boils, diarrhea, 
burns. Forms 




nationally.   
Overdose is associated 
with diarrhea †. 
Interaction with other 
drugs is also 
suspected    
Anthraquinone 
compounds 
                Rodriguez
Fragoso et al., 2008 
Poaceae Cymbopogon  Lemon LV Luo (8); Kikuyu Headache, Associated with GIT Unknown Fandohan et al., 2008 
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citratus Grass  (10) purify blood, 
clean pores 
irritation, potentially 
neurotoxic †   
Rhamnaceae Rahmnus 
prinoides 





Pygeum BK Meru and Mbere 
(6); Maasai (6 ) 
Cancer. 
Typhoid   





Kouso  LV Nandi (1); Meru 
(7); Kikuyu (10) 
















































DR Kikuyu (10); 
Masaai (6).  
ENT 
infections, 
Malaria   
May potentiate 
barbiturates, berries 







Duke et al ., 2002 
Verbenaceae Lantana  
camara 
Wild Sage  LV, RT Kikuyu(10);South 
coast (4); Luo 
(8); Maasai (6).   
Measles, sore 
throat, cough, 







Jordan  et al., 2011 
(a) Ethno medical information was obtained from Jeruto et al., 20061; Okello et al., 20102; Bussman et al., 20063; Nguta et al., 20104; Njoroge et al.,20105; 
Kigondu et al., 20116; Kirira et al , 20067;  Nagata et al., 20118; Kokwaro, 199310. 
(b). LV: leaves; RT: root; WP: Whole plant; BK: bark; SE: seed; ST: stem; FR: fruit; SP: sap; ENT, Ear nose and throat 
(c). † No health hazards known at proper dosage levels.  
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Hepatotoxicosis  
Hepatotoxicity is one of the biggest concerns raised by 
the indiscriminate use of herbal medicines. Ephedra 
and pyrrolizidine containing plants including Crotalaria, 
Heliotropium and Senecio spp. are commonly used in 
Kenya and have been associated with hepatoxicity 
(Huxtable, 1990; Stickel et al., 2005; Willet et al., 
2004; Ernst and  Pittler., 2003; Seeff et al., 2001). 
The reported liver pathologies range from mild 
elevation of liver enzymes to fulminant liver failure 
requiring liver transplantation (Pak et al., 2004). 
According to Steenkamp and colleagues, the excessive 
exposure to pyrrolizidine alkaloids may be responsible 
for the high rates of liver cancer, venoocclusive 
disease (VOD) and cirrhosis seen in Africa 
(Steenkamp, et al., 2000). In Kenya, Senecio species 
used by the Luo (Kokwaro, 1993) Meru, Mbeere 
(Kareru et al., 2008), Nandi (Jeruto et al., 2006) and 
the Miji Kenda (Nguta et al., 2010) are known to 
contain pyrrolizidine alkaloids. Research in animal’s 
studies indicates that unbound pyrroles are highly 
reactive hepatocarcinogens (Stickel et al., 2005). 
Another commonly used plant which may cause liver 
toxicity is Lantana camara which grows in most of the 
agroecological zones in Kenya. While the exact 
mechanism of toxicity is unknown, animal studies have 
demonstrated that extracts from the plant can cause 
widespread changes in mitochondrial, microsomal, and 
membrane enzymes resulting in cholestasis, 
hepatotoxicity, and photosensitization (Bevilacqua et 
al., 2011; Ernst and Pittler, 2003). Human fatalities 
have been attributed to ingestion of green berries 
(Duke et al., 2002). 
Gastro-intestinal tract toxicities  
Several herbs including Aloe sp., Cinnamomum 
caphora, Cassia didimobotrya, Warbugia salutaris, 
Melia azedarach, Turraea mombassana, Cocculus 
hirsutus, Olinia rochetiana, Pittosporum viridiflorum are 
known to contain toxins which are detrimental to the 
gastrointestinal tract (Duke et al., 2002). Toxalbumins, 
which are toxic to gastrointetsinal tract, have been 
isolated from plants such as Ricinus communis, Abrus 
precatorius, Jatropha curcas and Jatropha multifida 
(Levin et al., 2000). Some studies have shown that 
administration of the fruit of Jatropha curcas increases 
fetal resorptions when administered soon after 
implantation (Donald, 2008). Other toxins such as ricin 
and abrin which are derived from Ricinus communis 
and Abrus precatorius, respectively, feature highly on 
the list of substances which might be used in 
bioterrorism (Fennell et al., 2004). The compounds are 
highly toxic, heterodimeric type II ribosome inactivating 
proteins. Ingestion of meliatoxins, a toxin from ripe 
berries of Melia azedarach, has also been associated 
with vomiting and diarrhea in children (Ferreiro et al., 
2010). Aloe Vera, a herb which has found widespread 
commercial application, contains several biologically 
active constituents including emodin and anthrone 
(Duke et al., 2002). Emodin anthrones act as GI tract 
irritant. Therefore, it is generally contraindicated for 
patients with inflammatory intestinal diseases such as 
Crohn disease, ulcerative colitis, and irritable bowel 
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syndrome or to children less than ten years of age 
(Ibid).   
Cardiovascular system  
A number of cardenolidecontaining garden plants are 
used in traditional herbal formularies in Kenya. Over 
400 cardiac glycosides have been isolated from the 
plant kingdom. In Kenya, commonly used plants 
containing cardiac glycoside include Thevetia 
peruviana and Nerium oleander (Nagata et al., 2011; 
Nanyingi et al., 2008; Kirira et al., 2006).  High 
concentrations of cardiac glycosides are found in seed, 
stems, and roots, followed by the fruit (Donald, 2008). 
Overdosage of Nerium Oleander may cause 
arrhythmia, bradycardia, cardiodepression, confusion, 
cyanosis, diarrhea, headache, hyperkalemia, nausea, 
neurodepression, stupor and vomiting (Duke et al., 
2002). Another herb that is grown in Kenya and used 
as stimulant is Catha edulis (Khat). Habitual 
consumption of khat may enhance the risk of acute 
myocardial infarction and hypertension (Getahun et al., 
2010). Myocardial necrosis in rabbits fed on Senna 
occidentalis has also been reported (Yadav et al., 
2010). 
Genotoxicity  
A large proportion of plants which are used in 
traditional medicine in Kenya have in vitro mutagenic 
effects (Elgorashi et al., 2003; Fennell et al., 2004). A 
recent study in South Africa, which screened more 
than 50 plants sourced from different parts of the 
continent for genotoxicity showed that both polar and 
apolar extracts of some plants maybe genetoxic. 
Plants used locally which were shown to be to be 
highly toxic (caused both DNA damage and 
chromosomal aberrations) are Prunus africana, 
Rhamnus prinoides L’Hér, Ricinus communis and 
Trichelia emetica (Fennell et al., 2004).  Extracts 
derived from Euphorbiaceae sp. have also been linked 
to tumorigenesis (Norhanom and Yadav, 1995). 
According to some scholars, the high prevalence of 
Burkitt lymphoma in East Africa maybe associated with 
the commonplace use of these plants in folk medicine 
(Ibid). The observation is premised on the findings that 
extracts from some Euphorbiaceae sp. have Epstein 
Barr virus (EBV)  activating capacity (Ibid). Other 
locally used plants which have been linked to 
carcinogenesis include anthrone – containing laxatives 
from Aloe spp. While Aloe has been identified as a 
possible risk factor in colorectal cancer, the claim is 
still controversial since studies in rats suggest that 
Aloe can have antitumorigenic effects (Duke et al., 
2002).  
Toxicities associated with herb-conventional drug 
interactions  
The concurrent use of herbal preparations alongside 
conventional drugs raises concerns about possible 
adverse reactions due to drug–herbal interactions. 
Some constituents of herbal medicines can induce or 
inhibit enzymes involved in drug metabolism (Sahoo et 
al., 2010).  Evaluating how phytochemicals and 
cytochrome P450 interact has been proposed as a 
possible way of predicting both the therapeutic 
outcome of herbal medicines and possible side effects 
(Ibid). Competitive inhibition at the P450 active site 
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has been proposed as the putative point of herbdrug 
interaction in these reactions (Ulbright et al., 2008).  
At present, the number of studies on this subject is 
scant. However, several warnings have been issued 
on the strength of these studies. In Kenya, studies 
have shown that African potato (Hypoxis 
hemerocallidea) extracts which are sold to HIV patients 
may inhibit HAART drug metabolism and transport 
(Mills et al., 2006). Therefore, some experts are of the 
opinion that the concomitant use African potato 
extracts and HAART by HIV patients should be 
discouraged (Izzo, 2004). In addition, studies have 
shown that use of Allium sativum (garlic) supplements 
may reduce the plasma concentrations of the 
antiretrovirals (indinavir and saquinavir) (Williamson et 
al., 2009). Other studies have suggested that Aloe 
vera extracts, (Aloe gel) might have additive effects 
when used with antidiabetes drugs (Anuja et al., 
2010). Preliminary evidence suggests that aloe gel 
might lower blood glucose levels and may interact with 
conventional antidiabetic drugs (RodriguezFragoso 
et al., 2008) and increase the risk of hypoglycemia in 
some patients. Other studies suggest that excessive 
use of Aloe and cardiac glycoside drugs might 
potentiate diuretic induced potassium loss, increasing 
the risk of hypokalaemia. Since Aloe inhibits 
thromboxane A2 and prostaglandins; concomitant use 
with anticoagulants might prolong bleeding time (Ibid).  
Conclusion  
The toxicity associated with the use of herbs is largely 
underinvestigated and only a few studies have looked 
at toxicity of some herbs used in Kenya. At the same 
time, very few studies have focused on chronic toxicity 
or interactions with concurrently administered drugs. 
Therefore, toxicological investigations remain a high 
priority area. In recognition of this, we suggest that 
evaluation of toxicity should be included in the 
registration process. In addition, research has shown 
that the dangers associated with the use of herbal 
medicines are not necessarily inherent in the herbs 
themselves. Contamination (deliberate or otherwise), 
adulteration with conventional drugs, substitution, 
misidentification and concomitant herbdrug usage 
have also been cited as possible sources of danger. In 
view of this, enforcement of regulation including GMP, 
GACP and GSP should be prioritized. In addition, 
continuous monitoring of the quality of herbal 
medicines sold in the local market should be 
established and the public should be sensitized to the 
dangers of indiscriminate use of herbal medicines.   
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